Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study
The National Institute of Allergy and Infectious Diseases (at the National Institutes of Health) and Unitaid.
Authors
- Alina Nalyvayko (ORCID: https://orcid.org/0009-0006-0348-417X)
- Janré Steyn (ORCID: https://orcid.org/0000-0003-4475-1490)
- Timothy C. Rodwell (ORCID: https://orcid.org/0000-0003-2779-3197)
- Rebecca E. Colman (ORCID: https://orcid.org/0000-0002-6854-2100)
- Fahd Naufal (ORCID: https://orcid.org/0000-0001-6106-3177)
- John Metcalfe (ORCID: https://orcid.org/0000-0002-2279-7036)
- C. J. Opperman
- Jason Limberis (ORCID: https://orcid.org/0000-0002-7893-8416)
- Melanie Grobbelaar (ORCID: https://orcid.org/0000-0001-8138-5376)
- Sarishna Singh (ORCID: https://orcid.org/0000-0002-1794-4126)
- Yonas T Ghebrekristos
- Nabila A. Ismail
- Jennifer Williams
Institutions
- National Health Laboratory Service (ZA)
- South African Medical Research Council (ZA)
- San Francisco General Hospital (US)
- University of Cape Town (ZA)
- Stellenbosch University (ZA)
- University of California System (US)
- University of California San Diego (US)
- South African Tuberculosis Vaccine Initiative (ZA)
Publication Details
- Journal
- The Lancet Microbe
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1016/j.lanmic.2025.101293
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00